ARDSLEY ADVISORY PARTNERS LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.

Quarter-by-quarter ownership
ARDSLEY ADVISORY PARTNERS LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$2,962,000
-27.2%
140,000
-50.9%
0.47%
-53.7%
Q4 2018$4,067,000
-28.3%
285,000
+4.6%
1.02%
+33.6%
Q3 2018$5,676,000
-12.8%
272,500
-0.9%
0.76%
-21.9%
Q2 2018$6,509,000
+68.0%
275,000
+3.8%
0.98%
+68.5%
Q1 2018$3,874,000
+6.5%
265,000
+17.8%
0.58%
+31.4%
Q4 2017$3,636,000
+5493.8%
225,000
+2150.0%
0.44%
+4320.0%
Q1 2017$65,00010,0000.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders